Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Screeners Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Free account open.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 23 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Data quality

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Blog
RSS
Screeners
Newsletter
Key facts
Data
Insider Confidence Index

About
Contact
Pricing
Sign in
Privacy
Terms
Cookies

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-27. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Free account open · Pro on waitlist·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Healthcare & Pharma · InsiderTrades Sigma · page 21

Sector3,940

Healthcare & Pharma

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forma Therapeutics Holdings, Inc.

Forte Biosciences, Inc.

Fortress Biotech, Inc.

Forza Innovations Inc

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

Fresenius SE & Co. KGaA

Fulcrum Therapeutics, Inc.

Fulgent Genetics, Inc.

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A. ACQUISISCE CASA DI CURA CITTA’ DI ROMA / GAROFALO HEALTH CARE S.P.A. ACQUIRES CASA DI CURA CITTA' DI ROMA

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI / ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS ALZA IL RATING DI SOSTENIBILITA' / STANDARD ETHICS RAISES SUSTAINABILITY RATING

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS CONFERMA IL RATING ESG DI BREVE E MEDIO/LUNGO TERMINE / STANDARD ETHICS CONFIRMS SHORT-TERM AND MEDIUM/LONG-TERM ESG RATINGS

GAROFALO HEALTH CARE GHC ACQUISISCE LO STORICO GRUPPO ROMANO DA CUI HA TRATTO LE SUE ORIGINI / GHC ACQUIRES THE HISTORICAL ROMAN GROUP FROM WHICH IT DREW ITS ORIGINS

GAROFALO HEALTH CARE SPA

GMR Solutions Inc.

GT Biopharma, Inc.

GW Pharmaceuticals PLC

Previous 1...10...19 202122 23...30 40 50 60...79 Next